Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 13/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | KIT | P10721 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | MET | P08581 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2585775 | 0.82 | CYP3A4 (0.56) | CYP3A4CYP2C9CYP2C19 | |
| SCHEMBL2543533 | 0.79 | CYP2C19 (0.65) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL2540324 | 0.77 | CYP2C19 (0.57) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL2540030 | 0.77 | CYP3A4 (0.62) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL1883190 | 0.76 | CYP2C19 (0.81) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL2538827 | 0.75 | CYP3A4 (0.52) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL1884922 | 0.75 | CYP3A4 (0.70) | CYP3A4CYP2C9CYP2C19CSF1RKIT | |
| SCHEMBL2537798 | 0.75 | CYP3A4 (0.55) | CYP3A4CYP2C9CYP2C19CSF1RBRD4 | |
| SCHEMBL1883211 | 0.75 | CYP3A4 (0.71) | CYP3A4CYP2C9CYP2C19MET | |
| SCHEMBL1883624 | 0.75 | CYP3A4 (0.76) | CYP3A4CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2560972-A2 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | Plexxikon, Inc. (US) | 2013-02-27 | — | — | EP | disclosed |
| WO-2011133637-A2 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON, INC. (US) | 2011-10-27 | — | — | WO | disclosed |